+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Autoimmune Disease Therapeutics Market (2019-2025)

  • ID: 4825802
  • Report
  • July 2019
  • Region: Global
  • 269 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • ABBOTT Laboratories
  • AbbVie, Inc.
  • Amgen, Inc.
  • Bayer AG
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • MORE
The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period.

The autoimmune disease therapeutics market is anticipated to experience significant market growth during the forecast period due to early diagnosis of the disease, the latest launch of advanced therapy, and increased incidence of autoimmune disease. The market is witnessing a strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, olokizumab, apremilast, abatacept, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other hand, higher costs associated with sophisticated therapy are anticipated to hamper the market growth.

Autoimmune diseases happen when an individual's body's immune system treats and attacks healthy cells of his / her own body as foreign cells. These diseases trigger differences in the functioning of the organ, abnormal organ growth, and destruction of healthy body tissues. Autoimmune diseases are usually chronic and there's no curative treatment for them. Dermatomyositis, Hashimoto's disease of type 1 diabetes, Sjogren's syndrome, Psoriasis are some examples of autoimmune diseases. Systemic treatment of autoimmune diseases and localized treatment of autoimmune disease are two kinds of treatments for autoimmune disease.

Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Scope of the Study

Market Segmentation:

By Indication
  • Rheumatic Disease
  • Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Other Indications
By Drug Class
  • Anti-Inflammatory
  • Anti-Hyperglycemics
  • NSAIDs
  • Interferons
  • Other Drugs
By Distribution Channel
  • Hospital Pharmacy
  • Online
  • Retail Pharmacies and Drug Stores
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • ABBOTT Laboratories
  • Bio-Rad Laboratories, Inc.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Novartis AG
Unique Offerings from the Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ABBOTT Laboratories
  • AbbVie, Inc.
  • Amgen, Inc.
  • Bayer AG
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • MORE

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Autoimmune Disease Therapeutics Market, by Indication
1.4.2 Global Autoimmune Disease Therapeutics Market, by Drug Class
1.4.3 Global Autoimmune Disease Therapeutics Market, by Distribution Channel
1.4.4 Global Autoimmune Disease Therapeutics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Autoimmune Disease Therapeutics Market by Indication
3.1 Global Rheumatic Disease Market by Region
3.2 Global Diabetes Market by Region
3.3 Global Multiple Sclerosis Market by Region
3.4 Global Inflammatory Bowel Disease Market by Region
3.5 Global Other Indications Market by Region

Chapter 4. Global Autoimmune Disease Therapeutics Market by Drug Class
4.1 Global Anti-Inflammatory Market by Region
4.2 Global Anti-Hyperglycemics Market by Region
4.3 Global NSAIDs Market by Region
4.4 Global Interferons Market by Region
4.5 Global Other Drugs Market by Region

Chapter 5. Global Autoimmune Disease Therapeutics Market by Distribution Channel
5.1 Global Hospital Pharmacy Market by Region
5.2 Global Online Market by Region
5.3 Global Retail Pharmacies and Drug Stores Market by Region

Chapter 6. Global Autoimmune Disease Therapeutics Market by Region
6.1 North America Autoimmune Disease Therapeutics Market
6.1.1 North America Autoimmune Disease Therapeutics Market by Indication
6.1.1.1 North America Rheumatic Disease Market by Country
6.1.1.2 North America Diabetes Market by Country
6.1.1.3 North America Multiple Sclerosis Market by Country
6.1.1.4 North America Inflammatory Bowel Disease Market by Country
6.1.1.5 North America Other Indications Market by Country
6.1.2 North America Autoimmune Disease Therapeutics Market by Drug Class
6.1.2.1 North America Anti-Inflammatory Market by Country
6.1.2.2 North America Anti-Hyperglycemics Market by Country
6.1.2.3 North America NSAIDs Market by Country
6.1.2.4 North America Interferons Market by Country
6.1.2.5 North America Other Drugs Market by Country
6.1.3 North America Autoimmune Disease Therapeutics Market by Distribution Channel
6.1.3.1 North America Hospital Pharmacy Market by Country
6.1.3.2 North America Online Market by Country
6.1.3.3 North America Retail Pharmacies and Drug Stores Market by Country
6.1.4 North America Autoimmune Disease Therapeutics Market by Country
6.1.4.1 USA Autoimmune Disease Therapeutics Market
6.1.4.1.1 USA Autoimmune Disease Therapeutics Market by Indication
6.1.4.1.2 USA Autoimmune Disease Therapeutics Market by Drug Class
6.1.4.1.3 USA Autoimmune Disease Therapeutics Market by Distribution Channel
6.1.4.2 Canada Autoimmune Disease Therapeutics Market
6.1.4.2.1 Canada Autoimmune Disease Therapeutics Market by Indication
6.1.4.2.2 Canada Autoimmune Disease Therapeutics Market by Drug Class
6.1.4.2.3 Canada Autoimmune Disease Therapeutics Market by Distribution Channel
6.1.4.3 Mexico Autoimmune Disease Therapeutics Market
6.1.4.3.1 Mexico Autoimmune Disease Therapeutics Market by Indication
6.1.4.3.2 Mexico Autoimmune Disease Therapeutics Market by Drug Class
6.1.4.3.3 Mexico Autoimmune Disease Therapeutics Market by Distribution Channel
6.1.4.4 Rest of North America Autoimmune Disease Therapeutics Market
6.1.4.4.1 Rest of North America Autoimmune Disease Therapeutics Market by Indication
6.1.4.4.2 Rest of North America Autoimmune Disease Therapeutics Market by Drug Class
6.1.4.4.3 Rest of North America Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 Europe Autoimmune Disease Therapeutics Market
6.2.1 Europe Autoimmune Disease Therapeutics Market by Indication
6.2.1.1 Europe Rheumatic Disease Market by Country
6.2.1.2 Europe Diabetes Market by Country
6.2.1.3 Europe Multiple Sclerosis Market by Country
6.2.1.4 Europe Inflammatory Bowel Disease Market by Country
6.2.1.5 Europe Other Indications Market by Country
6.2.2 Europe Autoimmune Disease Therapeutics Market by Drug Class
6.2.2.1 Europe Anti-Inflammatory Market by Country
6.2.2.2 Europe Anti-Hyperglycemics Market by Country
6.2.2.3 Europe NSAIDs Market by Country
6.2.2.4 Europe Interferons Market by Country
6.2.2.5 Europe Other Drugs Market by Country
6.2.3 Europe Autoimmune Disease Therapeutics Market by Distribution Channel
6.2.3.1 Europe Hospital Pharmacy Market by Country
6.2.3.2 Europe Online Market by Country
6.2.3.3 Europe Retail Pharmacies and Drug Stores Market by Country
6.2.4 Europe Autoimmune Disease Therapeutics Market by Country
6.2.4.1 Germany Autoimmune Disease Therapeutics Market
6.2.4.1.1 Germany Autoimmune Disease Therapeutics Market by Indication
6.2.4.1.2 Germany Autoimmune Disease Therapeutics Market by Drug Class
6.2.4.1.3 Germany Autoimmune Disease Therapeutics Market by Distribution Channel
6.2.4.2 UK Autoimmune Disease Therapeutics Market
6.2.4.2.1 UK Autoimmune Disease Therapeutics Market by Indication
6.2.4.2.2 UK Autoimmune Disease Therapeutics Market by Drug Class
6.2.4.2.3 UK Autoimmune Disease Therapeutics Market by Distribution Channel
6.2.4.3 France Autoimmune Disease Therapeutics Market
6.2.4.3.1 France Autoimmune Disease Therapeutics Market by Indication
6.2.4.3.2 France Autoimmune Disease Therapeutics Market by Drug Class
6.2.4.3.3 France Autoimmune Disease Therapeutics Market by Distribution Channel
6.2.4.4 Russia Autoimmune Disease Therapeutics Market
6.2.4.4.1 Russia Autoimmune Disease Therapeutics Market by Indication
6.2.4.4.2 Russia Autoimmune Disease Therapeutics Market by Drug Class
6.2.4.4.3 Russia Autoimmune Disease Therapeutics Market by Distribution Channel
6.2.4.5 Spain Autoimmune Disease Therapeutics Market
6.2.4.5.1 Spain Autoimmune Disease Therapeutics Market by Indication
6.2.4.5.2 Spain Autoimmune Disease Therapeutics Market by Drug Class
6.2.4.5.3 Spain Autoimmune Disease Therapeutics Market by Distribution Channel
6.2.4.6 Italy Autoimmune Disease Therapeutics Market
6.2.4.6.1 Italy Autoimmune Disease Therapeutics Market by Indication
6.2.4.6.2 Italy Autoimmune Disease Therapeutics Market by Drug Class
6.2.4.6.3 Italy Autoimmune Disease Therapeutics Market by Distribution Channel
6.2.4.7 Rest of Europe Autoimmune Disease Therapeutics Market
6.2.4.7.1 Rest of Europe Autoimmune Disease Therapeutics Market by Indication
6.2.4.7.2 Rest of Europe Autoimmune Disease Therapeutics Market by Drug Class
6.2.4.7.3 Rest of Europe Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 Asia Pacific Autoimmune Disease Therapeutics Market
6.3.1 Asia Pacific Autoimmune Disease Therapeutics Market by Indication
6.3.1.1 Asia Pacific Rheumatic Disease Market by Country
6.3.1.2 Asia Pacific Diabetes Market by Country
6.3.1.3 Asia Pacific Multiple Sclerosis Market by Country
6.3.1.4 Asia Pacific Inflammatory Bowel Disease Market by Country
6.3.1.5 Asia Pacific Other Indications Market by Country
6.3.2 Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
6.3.2.1 Asia Pacific Anti-Inflammatory Market by Country
6.3.2.2 Asia Pacific Anti-Hyperglycemics Market by Country
6.3.2.3 Asia Pacific NSAIDs Market by Country
6.3.2.4 Asia Pacific Interferons Market by Country
6.3.2.5 Asia Pacific Other Drugs Market by Country
6.3.3 Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
6.3.3.2 Asia Pacific Online Market by Country
6.3.3.3 Asia Pacific Retail Pharmacies and Drug Stores Market by Country
6.3.4 Asia Pacific Autoimmune Disease Therapeutics Market by Country
6.3.4.1 China Autoimmune Disease Therapeutics Market
6.3.4.1.1 China Autoimmune Disease Therapeutics Market by Indication
6.3.4.1.2 China Autoimmune Disease Therapeutics Market by Drug Class
6.3.4.1.3 China Autoimmune Disease Therapeutics Market by Distribution Channel
6.3.4.2 Japan Autoimmune Disease Therapeutics Market
6.3.4.2.1 Japan Autoimmune Disease Therapeutics Market by Indication
6.3.4.2.2 Japan Autoimmune Disease Therapeutics Market by Drug Class
6.3.4.2.3 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
6.3.4.3 India Autoimmune Disease Therapeutics Market
6.3.4.3.1 India Autoimmune Disease Therapeutics Market by Indication
6.3.4.3.2 India Autoimmune Disease Therapeutics Market by Drug Class
6.3.4.3.3 India Autoimmune Disease Therapeutics Market by Distribution Channel
6.3.4.4 South Korea Autoimmune Disease Therapeutics Market
6.3.4.4.1 South Korea Autoimmune Disease Therapeutics Market by Indication
6.3.4.4.2 South Korea Autoimmune Disease Therapeutics Market by Drug Class
6.3.4.4.3 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
6.3.4.5 Singapore Autoimmune Disease Therapeutics Market
6.3.4.5.1 Singapore Autoimmune Disease Therapeutics Market by Indication
6.3.4.5.2 Singapore Autoimmune Disease Therapeutics Market by Drug Class
6.3.4.5.3 Singapore Autoimmune Disease Therapeutics Market by Distribution Channel
6.3.4.6 Malaysia Autoimmune Disease Therapeutics Market
6.3.4.6.1 Malaysia Autoimmune Disease Therapeutics Market by Indication
6.3.4.6.2 Malaysia Autoimmune Disease Therapeutics Market by Drug Class
6.3.4.6.3 Malaysia Autoimmune Disease Therapeutics Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Autoimmune Disease Therapeutics Market
6.3.4.7.1 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Indication
6.3.4.7.2 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
6.3.4.7.3 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 LAMEA Autoimmune Disease Therapeutics Market
6.4.1 LAMEA Autoimmune Disease Therapeutics Market by Indication
6.4.1.1 LAMEA Rheumatic Disease Market by Country
6.4.1.2 LAMEA Diabetes Market by Country
6.4.1.3 LAMEA Multiple Sclerosis Market by Country
6.4.1.4 LAMEA Inflammatory Bowel Disease Market by Country
6.4.1.5 LAMEA Other Indications Market by Country
6.4.2 LAMEA Autoimmune Disease Therapeutics Market by Drug Class
6.4.2.1 LAMEA Anti-Inflammatory Market by Country
6.4.2.2 LAMEA Anti-Hyperglycemics Market by Country
6.4.2.3 LAMEA NSAIDs Market by Country
6.4.2.4 LAMEA Interferons Market by Country
6.4.2.5 LAMEA Other Drugs Market by Country
6.4.3 LAMEA Autoimmune Disease Therapeutics Market by Distribution Channel
6.4.3.1 LAMEA Hospital Pharmacy Market by Country
6.4.3.2 LAMEA Online Market by Country
6.4.3.3 LAMEA Retail Pharmacies and Drug Stores Market by Country
6.4.4 LAMEA Autoimmune Disease Therapeutics Market by Country
6.4.4.1 Brazil Autoimmune Disease Therapeutics Market
6.4.4.1.1 Brazil Autoimmune Disease Therapeutics Market by Indication
6.4.4.1.2 Brazil Autoimmune Disease Therapeutics Market by Drug Class
6.4.4.1.3 Brazil Autoimmune Disease Therapeutics Market by Distribution Channel
6.4.4.2 Argentina Autoimmune Disease Therapeutics Market
6.4.4.2.1 Argentina Autoimmune Disease Therapeutics Market by Indication
6.4.4.2.2 Argentina Autoimmune Disease Therapeutics Market by Drug Class
6.4.4.2.3 Argentina Autoimmune Disease Therapeutics Market by Distribution Channel
6.4.4.3 UAE Autoimmune Disease Therapeutics Market
6.4.4.3.1 UAE Autoimmune Disease Therapeutics Market by Indication
6.4.4.3.2 UAE Autoimmune Disease Therapeutics Market by Drug Class
6.4.4.3.3 UAE Autoimmune Disease Therapeutics Market by Distribution Channel
6.4.4.4 Saudi Arabia Autoimmune Disease Therapeutics Market
6.4.4.4.1 Saudi Arabia Autoimmune Disease Therapeutics Market by Indication
6.4.4.4.2 Saudi Arabia Autoimmune Disease Therapeutics Market by Drug Class
6.4.4.4.3 Saudi Arabia Autoimmune Disease Therapeutics Market by Distribution Channel
6.4.4.5 South Africa Autoimmune Disease Therapeutics Market
6.4.4.5.1 South Africa Autoimmune Disease Therapeutics Market by Indication
6.4.4.5.2 South Africa Autoimmune Disease Therapeutics Market by Drug Class
6.4.4.5.3 South Africa Autoimmune Disease Therapeutics Market by Distribution Channel
6.4.4.6 Nigeria Autoimmune Disease Therapeutics Market
6.4.4.6.1 Nigeria Autoimmune Disease Therapeutics Market by Indication
6.4.4.6.2 Nigeria Autoimmune Disease Therapeutics Market by Drug Class
6.4.4.6.3 Nigeria Autoimmune Disease Therapeutics Market by Distribution Channel
6.4.4.7 Rest of LAMEA Autoimmune Disease Therapeutics Market
6.4.4.7.1 Rest of LAMEA Autoimmune Disease Therapeutics Market by Indication
6.4.4.7.2 Rest of LAMEA Autoimmune Disease Therapeutics Market by Drug Class
6.4.4.7.3 Rest of LAMEA Autoimmune Disease Therapeutics Market by Distribution Channel

Chapter 7. Company Profiles
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.4.5.2 Collaborations, partnerships and agreements:
7.4.5.3 Product launches:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Approval:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
7.9.1 Company overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
7.10.5.2 Collaborations, partnerships and agreements

Note: Product cover images may vary from those shown
3 of 3
  • ABBOTT Laboratories
  • Bio-Rad Laboratories, Inc.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll